1 / 7

HARM REDUCTION IN KENYA

As Presented By: Daniel Tinga Kalafa E-mail:- tingakalafa@yahoo.com Tel: +254-724 611 220. HARM REDUCTION IN KENYA. 1.INTRODUCTION.

kenna
Download Presentation

HARM REDUCTION IN KENYA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. As Presented By: Daniel Tinga Kalafa E-mail:- tingakalafa@yahoo.com Tel: +254-724 611 220 HARM REDUCTION IN KENYA

  2. 1.INTRODUCTION • Evidence from Kenya AIDS Indicator Survey (KAIS) shows that in 2008, an estimated 3.8 percent of new HIV infections were among Injecting Drug Users (IDUs), for which 5.8 % relates to Nairobi and 6.1 % to the Coast. We have worked in prevention of HIV amongst IDUs in Malindi, Kilifi, Mombasa and Nairobi since March 2005 • Our strategy is to Reach, Engage and Facilitate identified Drug Users (DUs) including Injecting Drug Users (IDUs) and vulnerable populations access quality Harm Reduction Services ,HIV prevention programmes including,HIV Testing and Counseling, Condom use, Bleach use education in cleaning Needles, HIV care including ARV.

  3. 2. GAPS • Estimated size of IDUs is not clear • Drug Dependence Treatment not affordable • The Government policy is against the Needle and Syringe Programme (NSP) and Medically Assisted Therapy (MAT). • Low access to HTC services, • Low adherence and compliance to ART • Low adherence and compliance to STI services

  4. GAPS Continued • Screening and treatment services for viral hepatitis are not accessible • Inconsistent supply of both male and female condoms • Some Religious organizations do not allow use of condoms • IEC and BCC materials are partially available and do not address the immediate needs of IDUs • Low adherence and compliance to TB services leading to drug resistance • Access to prisons is very limited.

  5. 3. CRITICAL ISSUES/RECOMENDATIONS • To adopt a Human Rights approach in policy and programming to Reduce Stigma and Discrimination vis a vis Injecting Drug Users and other Drug users. • To Lobby and Advocate for the introduction of NSP and MAT as prevention of HIV amongst IDUs • To formulate National Guidelines and Protocols for HIV prevention among DUs including IDUs, • To establish a National Surveillance system for Data collection, Analysis, Management and Reporting that can inform trends on drug use.

  6. CRITICAL ISSUES/RECOMENDATIONS cont. • To evaluate current projects working in HIV prevention amongst drug users in Kenya. • To scale up prevention of HIV and Harm Reduction services amongst IDUs in Kenya. • To actively involve DUs and IDUs in the development of national policies as well as to preparing IEC and BCC material.

  7. RIGHTS HERE,RIGHT NOW! Thank You!

More Related